Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P070026/S128

CERAMAX Ceramic Total Hip System

Depuy Orthopaedics, Inc. · Decision date Jul 24, 2026

FDA DECISIONP070026/S128

What did the FDA decide?

FDA records P070026/S128 as a supplement to PMA P070026, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 24, 2026.

FDA approval order statement

to automate the Air Gage inspection by replacing manual entry and paper records with direct Shop Floor Control (SFC) data capture following the CNC Machining process step for Summit Hip Stem components
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Orthopedic
Decision date
Jul 24, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P070026/S128
Regulatory pathway
PMA supplement
Product code
MRA
Decision code
OK30
Decision date
Jul 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented.

Product code
MRA
FDA device class
3

For the original device and its historical approval scope, see PMA P070026. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P070026 · Original PMA

    CERAMAX CERAMIC HIP SYSTEM

  2. P070026/S122 · Related supplement

    CERAMAX CERAMIC HIP SYSTEM

  3. P070026/S121 · Related supplement

    CERAMAX CERAMIC HIP SYSTEM

  4. P070026/S123 · Related supplement

    Ceramax Ceramic Hip System

  5. P070026/S118 · Related supplement

    Ceramax Ceramic Total Hip System

  6. P070026/S124 · Related supplement

    Ceramax Ceramic Hip System

  7. P070026/S125 · Related supplement

    Ceramax Ceramic Hip System

  8. P070026/S127 · Related supplement

    CERAMAX CERAMIC HIP SYSTEM

  9. P070026/S128 received

    Application receipt date recorded by FDA.

  10. P070026/S128 · FDA decision

    30-Day Notice

  11. P070026/S130 · Related supplement

    CERAMAX Ceramic Hip System

  12. P070026/S129 · Related supplement

    CERAMAX CERAMIC HIP SYSTEM

Timeline entries are records held by MedtechLedger for P070026. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P070026

Product / regulatory recordCompanyPathwayDecision dateSource
Depuy Orthopaedics, Inc.PMA approvalDec 23, 2010FDA
Depuy Orthopaedics, Inc.PMA supplementAug 1, 2025FDA
Depuy Orthopaedics, Inc.PMA supplementAug 5, 2025FDA
Depuy Orthopaedics, Inc.PMA supplementDec 9, 2025FDA
Depuy Orthopaedics, Inc.PMA supplementJan 8, 2026FDA
Depuy Orthopaedics, Inc.PMA supplementApr 10, 2026FDA
Depuy Orthopaedics, Inc.PMA supplementApr 29, 2026FDA
Depuy Orthopaedics, Inc.PMA supplementJun 3, 2026FDA
Depuy Orthopaedics, Inc.PMA supplementAug 27, 2026FDA
Depuy Orthopaedics, Inc.PMA supplementSep 4, 2026FDA

Explore the linked device profile

Other records with product code MRA

Product / regulatory recordCompanyPathwayDecision dateSource
HOWMEDICA OSTEONICS CORPPMA supplementSep 17, 2025FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Depuy Orthopaedics, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
700 Orthopaedic Dr., Warsaw, IN, 46582

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records